Cannabis company Tilray acquires majority stake in Medmen in bet on U.S. legalization

Tilray shares rose in extended trading Tuesday after it announced it acquired a majority stake in Medmen for $165.8 million.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.